Cargando…

Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia

The correlation of molecular and phenotypic evolution in individual patients with chronic myelomonocytic leukemia (CMML) is poorly investigated. The longitudinal follow up of a CMML patient for more than 10 years illustrates that the emergence of clones harboring mutations in TET2, SRSF2, RUNX1, MPL...

Descripción completa

Detalles Bibliográficos
Autores principales: Geissler, Klaus, Jäger, Eva, Gurbisz, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904770/
https://www.ncbi.nlm.nih.gov/pubmed/31867203
http://dx.doi.org/10.1016/j.lrr.2019.100185
_version_ 1783478053865783296
author Geissler, Klaus
Jäger, Eva
Gurbisz, Michael
author_facet Geissler, Klaus
Jäger, Eva
Gurbisz, Michael
author_sort Geissler, Klaus
collection PubMed
description The correlation of molecular and phenotypic evolution in individual patients with chronic myelomonocytic leukemia (CMML) is poorly investigated. The longitudinal follow up of a CMML patient for more than 10 years illustrates that the emergence of clones harboring mutations in TET2, SRSF2, RUNX1, MPL, NRAS, and finally in multiple genes, respectively, was mirrored by thrombocytopenia, thrombocytosis, myeloproliferation and transformation into acute myeloid leukemia. Moreover, molecular aberrations of the RAS genes were associated with markedly increased spontaneous in vitro myeloid colony formation which has been shown to be a functional indicator of RAS pathway hyperactivation.
format Online
Article
Text
id pubmed-6904770
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69047702019-12-20 Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia Geissler, Klaus Jäger, Eva Gurbisz, Michael Leuk Res Rep Article The correlation of molecular and phenotypic evolution in individual patients with chronic myelomonocytic leukemia (CMML) is poorly investigated. The longitudinal follow up of a CMML patient for more than 10 years illustrates that the emergence of clones harboring mutations in TET2, SRSF2, RUNX1, MPL, NRAS, and finally in multiple genes, respectively, was mirrored by thrombocytopenia, thrombocytosis, myeloproliferation and transformation into acute myeloid leukemia. Moreover, molecular aberrations of the RAS genes were associated with markedly increased spontaneous in vitro myeloid colony formation which has been shown to be a functional indicator of RAS pathway hyperactivation. Elsevier 2019-10-05 /pmc/articles/PMC6904770/ /pubmed/31867203 http://dx.doi.org/10.1016/j.lrr.2019.100185 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Geissler, Klaus
Jäger, Eva
Gurbisz, Michael
Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
title Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
title_full Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
title_fullStr Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
title_full_unstemmed Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
title_short Genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
title_sort genotypic and phenotypic evolution in a patient with chronic myelomonocytic leukemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904770/
https://www.ncbi.nlm.nih.gov/pubmed/31867203
http://dx.doi.org/10.1016/j.lrr.2019.100185
work_keys_str_mv AT geisslerklaus genotypicandphenotypicevolutioninapatientwithchronicmyelomonocyticleukemia
AT jagereva genotypicandphenotypicevolutioninapatientwithchronicmyelomonocyticleukemia
AT gurbiszmichael genotypicandphenotypicevolutioninapatientwithchronicmyelomonocyticleukemia